ABT-450, ritonavir, ombitasvir, and dasabuvir achieves 97% and 100% sustained virologic response with or without ribavirin in treatment-experienced patients with HCV genotype 1b infection.

Andreone, Pietro, Colombo, Massimo G, Enejosa, Jeffrey V, Koksal, Iftihar, Ferenci, Peter, Maieron, Andreas, Müllhaupt, Beat, Horsmans, Yves, Weiland, Ola, Reesink, Henk W, Rodrigues, Lino, Hu, Yiran B, Podsadecki, Thomas and Bernstein, Barry (2014) ABT-450, ritonavir, ombitasvir, and dasabuvir achieves 97% and 100% sustained virologic response with or without ribavirin in treatment-experienced patients with HCV genotype 1b infection. Gastroenterology, 147 (2). 359-365.e1. ISSN 1528-0012

Full text not available from this repository.

Item Type:	Article
Divisions:	Ordensklinikum Linz Barmherzige Schwestern > Interne IV: Gastroenterologie & Hepatologie, Endokrinologie und Stoffwechsel, Ernährungsmedizin
Depositing User:	Prof. Dr. Rainer Schöfl
Date Deposited:	16 Nov 2021 11:40
Last Modified:	17 Feb 2025 09:34
URI:	https://eprints.vinzenzgruppe.at/id/eprint/9335

Edit Item